Insider Stock Trading History of Galakatos Nicholas


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Galakatos Nicholas since year 2005. The trader's CIK number is 1252522. At the time of this reporting, Galakatos Nicholas is the Director of Ophthotech Corp. . (stock ticker symbol OPHT). See this page for all insider trading activities at Ophthotech Corp. .

Note that in the past GALAKATOS NICHOLAS also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Galakatos Nicholas since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-01-11 OPHT Ophthotech Corp. Sale 3,000 65.64 196,920
2015-12-10 OPHT Ophthotech Corp. Sale 3,000 64.27 192,804
2015-11-18 OPHT Ophthotech Corp. Sale 1,500 60.00 90,000
2015-11-09 OPHT Ophthotech Corp. Sale 1,500 60.00 90,000
2015-11-10 OPHT Ophthotech Corp. Sale 1,500 58.69 88,035
2015-11-02 OPHT Ophthotech Corp. Sale 1,500 54.00 81,000
2015-06-30 CATB Catabasis Pharmaceuticals Inc Buy 376,695 12.00 4,520,340
2014-06-12 OPHT Ophthotech Corp. Sale 47,217 44.51 2,101,675
2014-06-13 OPHT Ophthotech Corp. Sale 82,277 44.01 3,621,257
2014-06-16 OPHT Ophthotech Corp. Sale 15,482 44.00 681,208
2014-06-10 PTLA Portola Pharmaceuticals Inc Sale 1,369 23.36 31,979
2013-09-30 OPHT Ophthotech Corp. Buy 5,000 22.00 110,000
2010-06-25 SENO Senorx Inc Sale 161,293 10.97 1,769,384
2010-06-28 SENO Senorx Inc Sale 46,600 10.97 511,202
2010-04-26 SENO Senorx Inc Sale 1,000 10.05 10,050
2010-04-27 SENO Senorx Inc Sale 13,900 10.09 140,251
2010-04-23 SENO Senorx Inc Sale 1,900 10.07 19,133
2010-04-22 SENO Senorx Inc Sale 31,811 10.06 320,018
2008-04-16 MBRX Metabasis Therapeutics Inc Buy 71,866 2.34 168,166
2007-04-24 CRYO Cryocor Inc Buy 96,551 5.14 496,272
2005-09-30 MBRX Metabasis Therapeutics Inc Buy 699,659 5.86 4,100,001
2005-06-20 CRTX Critical Therapeutics Inc Buy 547,446 5.48 3,000,004

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Galakatos Nicholas (Director of Ophthotech Corp. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.